Guideline for the management of knee and hip osteoarthritis

Summary of recommendations

Strong recommendations against the intervention

Guideline for the management of knee and hip osteoarthritis

Download PDF

Table of contents

Recommendations

Oral opioids – Knee and/or hip

Recommendation

We do not recommend offering oral opioids for people with knee and/or hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Low (knee)

Very low (hip)

Refer to full recommendation

Transdermal opioids – Knee and/or hip

Recommendation

We do not recommend offering transdermal opioids for people with knee and/or hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Low

Refer to full recommendation

Doxycycline – Knee and/or hip

Recommendation

We do not recommend offering doxycycline for people with knee and/or hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Low (knee)
Very low (hip)

Refer to full recommendation

Strontium ranelate – Knee and/or hip

Recommendation

We do not recommend offering strontium ranelate for people with knee and/or hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Moderate

Refer to full recommendation

IL-1 inhibitors – Knee and/or hip

Recommendation

We do not recommend offering IL-1 inhibitors for people with knee and/or hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Low

Refer to full recommendation

FGF – Knee and/or hip

Recommendation

We do not recommend offering FGF for people with knee and/or hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Very low

Refer to full recommendation

Viscosupplementation injection – Hip

Recommendation

We do not recommend offering viscosupplementation injection for people with hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Low

Refer to full recommendation

Stem cell therapy – Knee and/or hip

Recommendation

We do not recommend offering stem cell therapy for people with knee and/or hip OA.

Strength of recommendation

Strong against recommendation

Quality of evidence

Very low

Refer to full recommendation

Arthroscopic, lavage and debridement, meniscectomy and cartilage repair – Knee

Recommendation

We do not recommend offering arthroscopic, lavage and debridement, meniscectomy and cartilage repair for people with knee OA unless the person also has mechanical symptoms of a clinically locked knee as per Australian Knee Society’s ‘Arthroscopy position statement’

Strength of recommendation

Strong against recommendation

Quality of evidence

Very low (lavage and debridement)
Low (meniscectomy)
Very low (cartilage repair)

Refer to full recommendation

Did you know you can now log your CPD with a click of a button?

Create Quick log

Strong recommendations against the intervention

Recommendations

Oral opioids – Knee and/or hip

Recommendation

Strength of recommendation

Quality of evidence

Transdermal opioids – Knee and/or hip

Recommendation

Strength of recommendation

Quality of evidence

Doxycycline – Knee and/or hip

Recommendation

Strength of recommendation

Quality of evidence

Strontium ranelate – Knee and/or hip

Recommendation

Strength of recommendation

Quality of evidence

IL-1 inhibitors – Knee and/or hip

Recommendation

Strength of recommendation

Quality of evidence

FGF – Knee and/or hip

Recommendation

Strength of recommendation

Quality of evidence

Viscosupplementation injection – Hip

Recommendation

Strength of recommendation

Quality of evidence

Stem cell therapy – Knee and/or hip

Recommendation

Strength of recommendation

Quality of evidence

Arthroscopic, lavage and debridement, meniscectomy and cartilage repair – Knee

Recommendation

Strength of recommendation

Quality of evidence

Related documents